Cite
IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway.
MLA
Chen, Yan, et al. “IBSP, a Potential Recurrence Biomarker, Promotes the Progression of Colorectal Cancer via Fyn/β-Catenin Signaling Pathway.” Cancer Medicine, vol. 10, no. 12, June 2021, pp. 4030–45. EBSCOhost, https://doi.org/10.1002/cam4.3959.
APA
Chen, Y., Qin, Y., Dai, M., Liu, L., Ni, Y., Sun, Q., Li, L., Zhou, Y., Qiu, C., & Jiang, Y. (2021). IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway. Cancer Medicine, 10(12), 4030–4045. https://doi.org/10.1002/cam4.3959
Chicago
Chen, Yan, Ying Qin, Mengmeng Dai, Liping Liu, Yong Ni, Qinsheng Sun, Lulu Li, Yaoyao Zhou, Cheng Qiu, and Yuyang Jiang. 2021. “IBSP, a Potential Recurrence Biomarker, Promotes the Progression of Colorectal Cancer via Fyn/β-Catenin Signaling Pathway.” Cancer Medicine 10 (12): 4030–45. doi:10.1002/cam4.3959.